Cargando…
Lipoprotein(a) in patients with breast cancer after chemotherapy: exploring potential strategies for cardioprotection
Developments in neoadjuvant and adjuvant chemotherapy (CHT) have led to an increase in the number of breast cancer survivors. The determination of an appropriate follow-up for these patients is of increasing importance. Deaths due to cardiovascular disease (CVD) are an important part of mortality in...
Autores principales: | Wang, Ziqing, Li, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515253/ https://www.ncbi.nlm.nih.gov/pubmed/37736722 http://dx.doi.org/10.1186/s12944-023-01926-9 |
Ejemplares similares
-
Anacetrapib as a potential cardioprotective strategy
por: Di Bartolo, Belinda A, et al.
Publicado: (2017) -
Current Cardioprotective Strategies for the Prevention of Radiation-Induced Cardiotoxicity in Left-Sided Breast Cancer Patients
por: Nikovia, Vasiliki, et al.
Publicado: (2023) -
Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action
por: Nagao, Manabu, et al.
Publicado: (2018) -
Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
por: Kourek, Christos, et al.
Publicado: (2022) -
Euterpe oleracea extract (açaí) exhibits cardioprotective effects after chemotherapy treatment in a breast cancer model
por: Alessandra-Perini, Jéssica, et al.
Publicado: (2023)